Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness

NCT ID: NCT05343390

Last Updated: 2025-02-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

841 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-01

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Having health workers assist HIV-infected persons with the recruitment and testing of their sexual contacts and biological children is an effective and efficient way of identifying additional HIV-infected persons in need of HIV treatment and HIV-uninfected persons in need of HIV prevention. However, in Malawi, a country with a generalized HIV epidemic, health workers lack the counseling and coordination skills to routinely assist their HIV-infected clients with these services. This study will determine how to help health workers to effectively and efficiently provide these services to their patients through a set of digital capacity-building tools.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Voluntary assisted contact tracing (ACT) is an evidence-based approach that efficiently identifies persons in need of HIV treatment and prevention. Malawi, like many countries in sub-Saharan Africa, has adopted ACT policies to support its "95-95-95" targets for HIV testing, treatment, and viral suppression.

However, Malawi's ACT implementation has been poor due to deficits in health worker capacity and clinical coordination. Through preliminary work, our team has 1) developed a set of implementation strategies (theory-based health worker training and continuous quality improvement processes) that address these barriers; 2) packaged these strategies into a blended learning platform that combines digital and face-to-face modalities; and 3) field-tested the package in Malawi with promising preliminary results. In this proposal, the package will be rigorously evaluated in Malawi for implementation, service uptake, and cost-effectiveness outcomes.

Through a two-arm pragmatic cluster randomized implementation trial, the proposed research will address these gaps through three specific aims. Twenty Malawian facilities in two districts will be randomized to receive the blended learning implementation package (enhanced) versus standard implementation package (standard). In the first aim, ACT implementation outcomes will be compared between the enhanced and standard arms. Health worker fidelity to ACT procedures will be assessed through audio-recorded ACT encounters. In the second aim, HIV service uptake outcomes will be compared between the enhanced and standard arms. In the third aim, cost and cost-effectiveness outcomes will be examined.

The findings will offer important insights and innovations into how to bridge the gap between ACT research and practice, a critical step towards achieving the 95-95-95 targets.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Human Immunodeficiency Virus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a cluster randomized control trial with 2:1 randomization (standard: enhanced).
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors
Participants and investigators will not be masked. For fidelity assessments, those coding audio recordings will be masked with respect to study arm.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Enhanced implementation strategy

digitally guided training and continuous quality improvement

Group Type EXPERIMENTAL

Enhanced implementation package

Intervention Type BEHAVIORAL

Individual training with teaching and modeling (tablet-guided, \~8 hours) Small group training with practice and feedback (tablet-guided, \~16 hours) Ongoing continuous quality improvement sessions (tablet-guided, \~2 hours/month)

Standard implementation package

Intervention Type BEHAVIORAL

Individual training with teaching (facilitator-guided, \~2 hours) Small group practice (facilitator-guided, \~1 hour) Ongoing clinic support (facilitator-guided, \~30 minutes/month)

Standard implementation strategy

standard training and clinical support

Group Type ACTIVE_COMPARATOR

Standard implementation package

Intervention Type BEHAVIORAL

Individual training with teaching (facilitator-guided, \~2 hours) Small group practice (facilitator-guided, \~1 hour) Ongoing clinic support (facilitator-guided, \~30 minutes/month)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Enhanced implementation package

Individual training with teaching and modeling (tablet-guided, \~8 hours) Small group training with practice and feedback (tablet-guided, \~16 hours) Ongoing continuous quality improvement sessions (tablet-guided, \~2 hours/month)

Intervention Type BEHAVIORAL

Standard implementation package

Individual training with teaching (facilitator-guided, \~2 hours) Small group practice (facilitator-guided, \~1 hour) Ongoing clinic support (facilitator-guided, \~30 minutes/month)

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* working full-time at one of the health facilities included in the study
* staff in Malawi's Assisted Contact Tracing program.


-\>=15 years

-potential index, contact, or parent or guardian of a potential index or contact

Exclusion Criteria

* conditions that would compromise ability of participant to provide informed consent, undergo study procedures safely, or prevent proper conduct of study


* conditions that would compromise ability of individual to provide informed consent, undergo study procedures safely, or prevent proper conduct of study
Minimum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of North Carolina, Chapel Hill

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nora E Rosenberg, PhD

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Balaka District Hospital

Balaka, , Malawi

Site Status

Balaka OPD Health Centre

Balaka, , Malawi

Site Status

Chiendausiku Health Centre

Balaka, , Malawi

Site Status

Kalembo Health Centre

Balaka, , Malawi

Site Status

Kankao Health Centre

Balaka, , Malawi

Site Status

Kwitanda Health Centre

Balaka, , Malawi

Site Status

Mbera Health Centre

Balaka, , Malawi

Site Status

Namanolo Health Centre

Balaka, , Malawi

Site Status

Namdumbo Health Centre

Balaka, , Malawi

Site Status

Phalula Health Centre

Balaka, , Malawi

Site Status

Phimbi Health Centre

Balaka, , Malawi

Site Status

Ulongwe Health Centre

Balaka, , Malawi

Site Status

Utale Health Centres

Balaka, , Malawi

Site Status

Chamba Dispensary

Machinga, , Malawi

Site Status

Chikweo Health Centre

Machinga, , Malawi

Site Status

Gawanani Health Centre

Machinga, , Malawi

Site Status

Kawinga Dispensary

Machinga, , Malawi

Site Status

Machinga District Hospital

Machinga, , Malawi

Site Status

Mahinga Health Centre

Machinga, , Malawi

Site Status

Mangamba Health Centre

Machinga, , Malawi

Site Status

Mbonechela Dispensary

Machinga, , Malawi

Site Status

Mkwepere Health Centre

Machinga, , Malawi

Site Status

Mpiri Health Centre

Machinga, , Malawi

Site Status

Mposa Health Centre

Machinga, , Malawi

Site Status

Namandanje Health Centre

Machinga, , Malawi

Site Status

Namanja Health Centre

Machinga, , Malawi

Site Status

Nayinunje Health Centre

Machinga, , Malawi

Site Status

Nayuchi Health Centre

Machinga, , Malawi

Site Status

Ngokwe health Centre

Machinga, , Malawi

Site Status

Nsanama Health Centre

Machinga, , Malawi

Site Status

Ntaja Health Centre

Machinga, , Malawi

Site Status

Nthorowa Health Centre

Machinga, , Malawi

Site Status

Nyambi Health Centre

Machinga, , Malawi

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Malawi

References

Explore related publications, articles, or registry entries linked to this study.

Meek CJ, Munkhondya TEM, Mphande M, Tembo TA, Chitani M, Jean-Baptiste M, Vansia D, Kumbuyo C, Wang J, Simon KR, Rutstein SE, Barrington C, Kim MH, Go VF, Rosenberg NE. Examining the feasibility of assisted index case testing for HIV case-finding: a qualitative analysis of barriers and facilitators to implementation in Malawi. BMC Health Serv Res. 2024 May 9;24(1):606. doi: 10.1186/s12913-024-10988-z.

Reference Type DERIVED
PMID: 38720312 (View on PubMed)

Tembo TA, Mollan K, Simon K, Rutstein S, Chitani MJ, Saha PT, Mbeya-Munkhondya T, Jean-Baptiste M, Meek C, Mwapasa V, Go V, Bekker LG, Kim MH, Rosenberg NE. Does a blended learning implementation package enhance HIV index case testing in Malawi? A protocol for a cluster randomised controlled trial. BMJ Open. 2024 Jan 22;14(1):e077706. doi: 10.1136/bmjopen-2023-077706.

Reference Type DERIVED
PMID: 38253452 (View on PubMed)

Meek CJ, Munkhondya TEM, Mphande M, Tembo TA, Chitani M, Jean-Baptiste M, Vansia D, Kumbuyo C, Simon KR, Rutstein SE, Barrington C, Kim MH, Go VF, Rosenberg NE. Examining the feasibility of assisted index case testing for HIV case-finding: a qualitative analysis of barriers and facilitators to implementation in Malawi. Res Sq [Preprint]. 2023 Sep 8:rs.3.rs-3314925. doi: 10.21203/rs.3.rs-3314925/v1.

Reference Type DERIVED
PMID: 37720011 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01MH124526

Identifier Type: NIH

Identifier Source: secondary_id

View Link

20-1810

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.